Search Within

Miguel A Miranda-Roman

Formats
  1. Journal Article (4)
  2. Meeting Abstract (2)
Groups
  1. Alumni (GSK) (6)
  2. Department of Medicine (6)
  3. GSK Faculty (6)
  4. Gerstner Sloan Kettering Graduate School of Biomedical Sciences (6)
  5. Human Oncology and Pathogenesis Program (6)
  6. MSK Grad Students (6)

More Groups

People
  1. Ping Chi (6)
  2. Amish Patel (5)
  3. Cindy Lee (5)
  4. Juan Yan (5)
  5. Sarah Warda (5)
  6. Yu Chen (5)

More People

Years
  1. 2024 (1)
  2. 2022 (5)
Publications
  1. Clinical Cancer Research (2)
  2. Cancer Discovery (1)
  3. Cancer Research (1)
  4. Journal of Clinical Investigation (1)
  5. Nature Communications (1)
Publishers
  1. American Association for Cancer Research (4)
  2. American Society for Clinical Investigation (1)
  3. Nature Publishing Group (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MEK inhibitors lead to PDGFR pathway upregulation and sensitize tumors to RAF dimer inhibitors in NF1-deficient malignant peripheral nerve sheath tumor
    Journal Article

    Miranda-Román, M. A.; Lee, C. J.; Fishinevich, E.; Ran, L.; Patel, A. J.; Yan, J.; Khudoynazarova, M. N.; Warda, S.; Pachai, M. R.; Chen, Y.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert tumor microenvironment
    Meeting Abstract

    Yan, J.; Chen, Y.; Patel, A. J.; Lee, C. J.; Warda, S.; Nixon, B. G.; Wong, E. W. P.; Miranda-Román, M. A.; Yang, N.; Wang, Y.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • PRC2 inactivating mutations amplify cell death in response to DNMT1-targeted therapy through enhanced viral mimicry in malignant peripheral nerve sheath tumor
    Meeting Abstract

    Chi, P.; Patel, A. J.; Warda, S.; Maag, J. L. V.; Misra, R.; Miranda-Román, M. A.; Pachai, M. R.; Lee, C. J.; Li, D.; Wang, N.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert microenvironment and is sensitized by immunogenic viruses
    Journal Article

    Yan, J.; Chen, Y.; Patel, A. J.; Warda, S.; Lee, C. J.; Nixon, B. G.; Wong, E. W. P.; Miranda-Román, M. A.; Yang, N.; Wang, Y.; more...
    Journal of Clinical Investigation (2022)

    Fulltext@MSK | Save
  • PRC2-inactivating mutations in cancer enhance cytotoxic response to DNMT1-targeted therapy via enhanced viral mimicry
    Journal Article

    Patel, A. J.; Warda, S.; Maag, J. L. V.; Misra, R.; Miranda-Román, M. A.; Pachai, M. R.; Lee, C. J.; Li, D.; Wang, N.; Bayshtok, G.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer
    Journal Article

    Lopez, A.; Reyna, D. E.; Gitego, N.; Kopp, F.; Zhou, H.; Miranda-Roman, M. A.; Nordstrøm, L. U.; Narayanagari, S. R.; Chi, P.; Vilar, E.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save